Singapore markets close in 7 hours 24 minutes
Straits Times Index
3,286.61 -1.14 (-0.03%) Nikkei
37,695.35 +66.87 (+0.18%) Hang Seng
17,336.20 +51.66 (+0.30%) FTSE 100
8,078.86 +38.48 (+0.48%) Bitcoin USD
64,218.92 -329.10 (-0.51%) CMC Crypto 200
1,381.78 -0.79 (-0.06%)
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0800 |
| Open | 1.0500 |
| Bid | 1.0500 x 1200 |
| Ask | 1.0800 x 1200 |
| Day's range | 1.0400 - 1.0992 |
| 52-week range | 0.4200 - 2.0500 |
| Volume | |
| Avg. volume | 2,049,787 |
| Market cap | 276.007M |
| Beta (5Y monthly) | 2.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5300 |
| Earnings date | 04 Mar 2024 - 08 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
ZacksAdaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
Simply Wall St.Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Adaptimmune Therapeutics ( NASDAQ:ADAP ) Full Year 2023 Results Key Financial Results Revenue: US$60.3m (up 122% from...
GuruFocus.comAdaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results
Key Financial Highlights and Business Updates
© 2024 Yahoo. All rights reserved.